Jim Cramer’s ‘Mad Money’ Lightning Round: Insights on Applied Materials, Aflac, and More

During CNBC’s ‘Mad Money Lightning Round’, Jim Cramer offered his insights on a range of companies, providing recommendations and expressing his views on their prospects.

He started by recommending Applied Materials, stating that he believes the company is performing well despite potential concerns from the government due to their significant business presence in China. However, Cramer was less enthusiastic about Aflac, stating it’s not his favorite choice in the insurance sector. He instead preferred Chubb Ltd.

Cramer advised steering clear of Albemarle, a lithium producer. When discussing Elevance Health, he emphasized his preference for UnitedHealth Group as the leader in the healthcare space.

He expressed strong negativity towards Snap, calling it ‘not investable’ and deeming the company ‘irrelevant’.

Cramer categorized Main Street Capital as a business development company, a category he generally avoids due to a lack of trust.

Regarding Alibaba, he highlighted the company’s low stock price and predicted a strong earnings report. However, he cautioned that the market could react negatively to potential issues.

This segment of ‘Mad Money’ offered viewers a snapshot of Cramer’s perspectives on various companies, providing insights into his investment strategies and market analysis.

Related posts:

Jim Cramer’s ‘Mad Money’ Lightning Round: Cheniere Energy, GE Vernova, HubSpot, NuScale Power, AST SpaceMobile, and DexCom Jim Cramer’s ‘Mad Money’ Lightning Round: Target, Unity Software, Merck & More Cramer’s Lightning Round: VICI Properties, STMicroelectronics, Tetra Tech, Crown Castle, Schlumberger, New Fortress Energy, and Pure Storage